Subscribe To

Price Alert Latest News Economic Calendar News

ADUS / Addus HomeCare Corporation (ADUS) CEO Dirk Allison on Q1 2022 Results - Earnings Call Transcript

Addus HomeCare Corporation (NASDAQ:ADUS ) Q1 2022 Earnings Conference Call May 3, 2022 9:00 AM ET Company Participants Dru Anderson - Investor Relations Dirk Allison - Chairman and Chief Executive Officer Brian Poff - Chief Financial Officer Brad Bickham - President and Chief Operating Officer Conference Call Participants Scott Fidel - Stephens Joanna Gajuk - Bank of America Madeline Mollman - William Blair Brian Tanquilut - Jefferies Mitra Ramgopal - Sidoti Operator Good day and welcome to the Addus HomeCare's First Quarter 2022 Earnings Conference Call. All participants are in a listen-only mode. Read More

Demo Live Account See Partner Details

Content Topics

Addus

Homecare

Corporation

ADUS

Dirk

Allison

2022

Results

adus

Earnings

Transcript

Stock

Posted: May 3 2022, 14:40

Author Name: Seeking Alpha

ADUS News

By Zacks Investment Research
October 30, 2023

Addus HomeCare (ADUS) Q3 Earnings and Revenues Top Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to e

By Zacks Investment Research
October 26, 2023

Can Stocks Enjoy Halloween Effect Despite Rising Rate Fear?

The spooky occasion Halloween can turn into an occasion of angels for Wall Street. Top-ranked sectors like energy, construction, medical and utilities

By Zacks Investment Research
October 19, 2023

ADUS vs. USPH: Which Stock Is the Better Value Option?

Investors looking for stocks in the Medical - Outpatient and Home Healthcare sector might want to consider either Addus HomeCare (ADUS) or U.S. Physic

By Zacks Investment Research
October 10, 2023

Are Investors Undervaluing Addus HomeCare (ADUS) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Neverthe

By Zacks Investment Research
October 3, 2023

ADUS vs. USPH: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Outpatient and Home Healthcare sector have probably already heard of Addus HomeCare (ADUS) and U.S.

By Seeking Alpha
August 1, 2023

Addus HomeCare Corporation (ADUS) Q2 2023 Earnings Call Transcript

Addus HomeCare Corporation (NASDAQ:ADUS ) Q2 2023 Earnings Conference Call August 1, 2023 9:00 AM ET Company Participants Dru Anderson – FINN Partne

By Zacks Investment Research
July 31, 2023

Addus HomeCare (ADUS) Q2 Earnings and Revenues Beat Estimates

Addus HomeCare (ADUS) came out with quarterly earnings of $1.07 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earn

By Zacks Investment Research
July 20, 2023

Why Addus HomeCare (ADUS) Could Beat Earnings Estimates Again

Addus HomeCare (ADUS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likel

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.